OCT 04, 2021 3:00 AM PDT

Good News for Coffee Lovers: A New Study Finds Caffeine Does Not Impact Breast Cancer Risk

WRITTEN BY: Katie Kokolus

Reports indicate that caffeine consumption in the United States is greatest in adults aged 50 – 64.  Coincidentally, 63 is the average age of breast cancer diagnosis in women in the United States.  Further, on average, women undergo menopause at age 51.  

Notably, there is overlap in the age where women have a high incidence of breast cancer diagnosis and high caffeine consumption, and women of this age are postmenopausal.  These statistics have led to a common research question: does caffeine consumption impact breast cancer risk in postmenopausal women?

While many research programs have explored the relationship between these three factors, the results remain largely inconsistent. Some reports suggest caffeine is associated with increased breast cancer incidence, while others demonstrate lower breast cancer incidence in caffeine consumers. 

Despite the ambiguity, a recent study published in the International Journal of Cancer investigated the relationship between breast cancer and caffeine in postmenopausal women and found no association.

The study included a cohort of almost 80,000 participants in the Women’s Health Initiative Observational Study. This long-term national health study has followed a large group of women for decades. Women enrolled in the study complete yearly health questionnaires that scientists and clinicians across the country can access to investigate research related to health and disease.  

The researchers identified 4,719 cases of invasive breast cancer among postmenopausal participants.  Caffeine intake was based on self-reported frequency of daily caffeinated coffee and tea consumption. 

While the study detected no association between overall tea consumption and invasive breast cancer, the authors acknowledged that this data needs further investigation due to the small number of tea drinkers identified and the inability to account for different types of tea. 

Initial findings suggested that participants who consumed 2-3 daily cups of caffeinated coffee had a 12% higher risk of invasive breast cancer than nondrinkers.  However, this analysis did not yet consider specific factors which are known to influence breast cancer risk.

Demographic, lifestyle, and reproductive characteristics, including age, race, smoking status, body mass index, history of hormone therapy use, alcohol intake, and breast cancer subtype, were analyzed to scrutinize this data further.

After accounting for all these factors, the research team determined no meaningful association between caffeine intake from coffee and tea and invasive breast cancer risk.  The dependence of many demographic characteristics on the association between breast cancer and caffeine indicates a highly complex relationship. 

 

Sources:  caffeine consumption, breast cancer diagnosis, menopauseInternational Journal of CancerWomen’s Health Initiative Observational Study

 

About the Author
PhD
PhD in Tumor Immunology. I am interested in developing novel strategies to improve the efficacy of immunotherapies used to extend cancer survivorship.
You May Also Like
AUG 01, 2022
Cancer
Cannabis Helps Cancer Patients Combat Nausea and Vomiting
AUG 01, 2022
Cannabis Helps Cancer Patients Combat Nausea and Vomiting
A growing number of states have legalized marijuana for medical and/or recreational purposes.  Cannabis is a plant ...
AUG 10, 2022
Plants & Animals
Locusts Can "Detect" Cancer Cells
AUG 10, 2022
Locusts Can "Detect" Cancer Cells
New research published by a team at Michigan State University shows that locusts can both detect cancer cells and tell t ...
SEP 15, 2022
Immunology
How a Cancer-Causing Virus Evades Human Immunity
SEP 15, 2022
How a Cancer-Causing Virus Evades Human Immunity
While our immune system is usually able to identify and destroy pathogenic invaders like bacteria and viruses, those mic ...
OCT 17, 2022
Clinical & Molecular DX
New Study Shows Biological Differences in the Second-Most Common Type of Breast Cancer
OCT 17, 2022
New Study Shows Biological Differences in the Second-Most Common Type of Breast Cancer
Though invasive lobular carcinoma (ILC) is the second-most common type of breast cancer, it has historically been resear ...
NOV 02, 2022
Clinical & Molecular DX
New Genetic Variants Identified as Risk Factors for Ovarian Cancer
NOV 02, 2022
New Genetic Variants Identified as Risk Factors for Ovarian Cancer
Ovarian cancer is a complex disease resulting from mutated cells in the ovaries. As the cells multiply, they can invade ...
NOV 28, 2022
Clinical & Molecular DX
Study Indicates that Breast Cancer Recurrence Could be Predicted Using a MicroRNA Biomarker
NOV 28, 2022
Study Indicates that Breast Cancer Recurrence Could be Predicted Using a MicroRNA Biomarker
MicroRNAs are small (between just 21 and 23 nucleotides), non-coding RNA molecules. They are involved in the post-transc ...
Loading Comments...